Abstract:J A Mansurova, Andrey Orekhov, A S Zhunuspekova, A A Kassymova, L K Karazhanova Department of Therapy, Non-Commercial Joint-Stock Company "Semey Medical University", Semey, The Republic of Kazakhstan Correspondence: Andrey Orekhov, Department of Therapy, Non-Commercial Joint-Stock Company "Semey Medical University", Molodogvardeyskaya 34-1 Street, Semey, F18E9T9, The Republic of Kazakhstan, Tel +87774141476, Email Background: The objective of this study is to examine the impact of medication adherence on the timing of non-cardiovascular serious events (NCDS) onset in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods: This prospective study was conducted at a single center and involved 220 ACS patients who underwent sequential PCI with stenting. The Morisky Green Levine Medication Adherence Scale was employed to assess adherence to dual antiplatelet therapy (DAPT) and its impact on NCDS occurrence. Early in their hospitalization, all patients received education at the Coronary Heart Disease School. The survival rates of patients in both the main group and a control group (n=355) were subsequently evaluated. Results: The study findings indicated an inverse relationship between stent thrombosis development (Rho=− 0.334; p=0.001) and the timing of recurrent myocardial ischemia. There was also an inverse correlation between patient adherence and stent thrombosis development (Rho=− 0.275; p=0.009). Non-adherent individuals had a 16.8 times higher likelihood of experiencing stent thrombosis compared to compliant patients (p< 0.001). Following participation in the CHD School program, treatment adherence increased from 56.5% to 88.2%. Education for ACS patients post-stenting was significantly associated with all-cause mortality within the first 6 months (p=0.040). Conclusion: Secondary preventive measures, including education, impact the success of endovascular interventions in both the early hospital phase and the long term. Patient education can serve as a supplementary intervention to enhance DAPT adherence, thus diminishing the risk of recurrent cardiovascular events and mortality post endovascular intervention. Keywords: acute coronary syndrome, percutaneous coronary intervention, adherence, education, dual antiplatelet therapy Coronary heart disease (CHD) remains the leading cause of premature mortality among individuals in good physical condition, resulting in over 7 million fatal cases annually. 1 Among the various manifestations of CHD, acute coronary syndrome (ACS) stands out as particularly severe, carrying a significant risk of adverse cardiovascular outcomes. The widespread adoption of early invasive treatment strategies for ACS has notably enhanced patient outcomes, 2 but ongoing monitoring of such patients has unveiled novel challenges, including recurrent episodes of ischemia, thrombosis, and stent restenosis. Inadequate adherence to long-term treatment regimens following coronary interventions stands as a primary factor contributing to the suboptimal efficacy of therapies. 3 This deficiency leads to heightened occurrences of recurrent cardiovascular complications and elevated mortality rates, consequently escalating healthcare expenditures. Statistical data indicate that merely 40–75% of patients sustain secondary prevention practices post-intervention. 4 Enhancing patient compliance can be achieved through approaches such as training initiatives 5 and the emergence of remote monitoring systems for patients. 6 However, the comprehensive benefits of educating ACS patients have not undergone exhaustive exploration. Nonetheless, current guidelines underscore the importance of comprehensive rehabilitation, 7 including educational components, 8 for individuals with cardiovascular disorders. Thus, the objective of this study was to analyze the influence of treatment adherence on the temporal emergence of adverse cardiovascular complications in ACS patients who have undergone percutaneous coronary interventions (PCI). Additionally, the study aimed to assess the contribution of patient education to secondary prevention efforts targeting ischemic events. This prospective investigation encompassed a cohort of 220 patients diagnosed with acute coronary syndrome (ACS) who were admitted to the cardiology department of the University Hospital "SMU" in the Republic of Kazakhstan. The study spanned from January 2018 to September 2019 and focused on patients who had undergone coronary artery angiography (CAG) followed by stenting of the infarct-related artery. Within this patient group, a subset of 89 individuals (40.5%) experienced recurrent myocardial ischemia after previous percutaneous coronary -Abstract Truncated-

Results of a survey assessing provider beliefs of adherence barriers to antiplatelet medications

Patient and Physician Perspectives on the Benefits and Risks of Antiplatelet Therapy for Acute Coronary Syndrome

Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events

How to Improve Very Low Adherence to Anticoagulation Therapy in Elderly Patients with Non-Valvular Atrial Fibrillation

[Long-term management of post acute coronary syndrome with oral antiplatelet therapy]

Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study

Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

Adherence to dual anti-platelet therapy after acute coronary syndrome and its impact on patient outcome

Investigation and Research on Antiplatelet Therapy Adherence in Patients after 1 Year of Percutaneous Coronary Intervention

Evidence for clinician underprescription of and patient non-adherence to guideline-recommended cardiovascular medications among adults with peripheral artery disease: protocol for a systematic review and meta-analysis

Understanding physician and consumer attitudes concerning cholesterol management: results from the National Lipid Association surveys

Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence

Investigation on Compliance of Anti-Platelet Therapy after Coronary Stent Implantation

Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors

Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects